Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Crunchfish Governance from a strategic development perspective in focus at webinar

Crunchfish Governance was the topic of the 20th Survival of the fittest webinar. Crunchfish’s chairman presented Granitors’ strategic platform for business development followed by a panel discussion with board members at Crunchfish.In this webinar on Crunchfish Governance , the 20th of the Survival of the fittest webinar series , Crunchfish’s Chairman of the Board Göran Linder presented Granitor’s strategic business development platform. A panel discussion followed with Göran Linder, Board member Susanne Hannestad and

Herantis Pharma to Participate in Redeye Growth Day in June

Herantis Pharma Plc, Press Release, 27 May 2022 at 13:00 EEST   Herantis Pharma Plc (“Herantis”), developing disease modifying therapies for Parkinson’s disease, today announced that interim CEO Frans Wuite will be presenting at the Redeye Growth Day on June 2th, 2022.   Redeye Growth Day The presentation will be live on the Redeye platform at 9:25 a.m. CEST Follow this link to the event: Redeye Growth Day.  The presentations will be available via digital libraries, which are accessible to event participants

Toivo Group Oyj - Managers' Transactions - Asko Myllymäki

Toivo Group Oyj - Managers' Transactions - 27 May 2022 at 12:30 p.m. ____________________________________________ Person subject to the notification requirement Name: Asko Myllymäki Position: Member of the Board/Deputy member Issuer: Toivo Group Oyj LEI: 743700N31WYJDNPT8M98 Notification type: INITIAL NOTIFICATION Reference number: 15577/4/4 ____________________________________________ Transaction date: 2022-05-24 Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME) Instrument type: SHARE ISIN: FI4000496716 Nature of the transaction: ACQUISITION

Update on Financing Arrangements

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY RESTRICTED JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.On 9 May 2022 Pagero Group AB (publ) (“Pagero”) announced that it had agreed with Tungsten Corporation plc (“Tungsten”) the terms of a recommended cash offer for the entire issued and to be issued ordinary share capital of Tungsten (the “Offer”). On 19 May 2022, Pagero published its Offer Document setting out the full terms and conditions of the Offer. In

Neste and ITOCHU celebrate first Sustainable Aviation Fuel delivery to Etihad Airways in Japan

Neste Corporation, Press Release, 27 May 2022 at 12.00 p.m. (EET) Today, Neste and ITOCHU are celebrating the first delivery of Neste MY Sustainable Aviation Fuel™  to Etihad Airways, one of the airlines of the United Arab Emirates, in Japan. The delivery of Neste MY Sustainable Aviation Fuel (SAF) to Etihad marks the first time in Japan that SAF will be supplied to an overseas airline at an airport in Japan. The SAF will be delivered to Etihad’s aircraft at Narita International Airport.This milestone is a result of the

Realheart’s CEO Presents Blood Results at the ISMCS Conference in Hannover

Press release 27 May, 2022 Realheart's CEO Ina Laura Perkins is holding a presentation today at the annual meeting for the International Society for Mechanical Circulatory Support in Hannover, where she will give an update on the process of developing the world's first artificial four-chamber heart and will also share the results achieved so far through blood tests.Blood testing is a key activity in Realheart's development work, as the aim is to achieve as low blood damage as possible to move away from the side effects that have so far hampered the use of artificial hearts as a treatment

AI profile joins Speqta's board

Errol Koolmeister, leading AI profile, has been elected to Speqta AB's ("Speqta") board. He will add important expertise when the tech company Speqta continues its investment in AI in ecommerce. Errol Koolmeister has deep AI experience after implementing the technology in several large companies. Among other things, he has been Head of AI at H&M and worked with AI at Nordea and Vodafone. Errol Koolmeister comments:"I see great potential in Speqta and the company's ability to create value in the huge Google shopping channel. AI technology is the future of e-commerce and I

Kommuniké från årsstämma i BPC Instruments AB / Resolutions of the Annual General Meeting of BPC Instruments AB

BPC Instruments AB, org.nr. 556687-2460, höll årsstämma fredagen den 27 maj 2022. Med anledning av den fortsatta smittspridningen av viruset som orsakar covid-19 genomfördes stämman enbart med poströstning utan fysiskt deltagande. Idag antog BPC Instruments AB ("BPC" eller "Bolaget") följande resolutioner vid årsstämman: BPC Instruments AB, reg.no. 556687-2460, held its Annual General Meeting on Friday on May 27[th,] 2022. Due to the continued spread of the virus that causes covid-19, the meeting was conducted by postal voting only without physical participation. Today, BPC Instruments AB (

SOFTSWISS Jackpot Aggregator Launches

The SOFTSWISS Jackpot Aggregator makes the next step towards broadening the player experience with the launch of the first global campaign across MGA licensed brands. This became possible after starting cooperation with SlotHunter, a popular online casino working under the Maltese jurisdiction.Recently, the Jackpot Aggregator announced the first local campaign in Malta for N1 Casino. Thanks to the partnership with SlotHunter, another brand within the same casino group, the local campaign turned into a global one and united the two reputable casino brands. The audience of both projects now

XMReality selected by several Swedish energy companies and municipalities

XMReality AB has signed new deals with several Swedish energy companies and municipalities for the use of XMReality Remote Guidance. The main use case is technical support directly to the end customer.As previously communicated, Tekniska Verken in Linköping signed a multi-year contract with XMReality and now Tekniska Verken in Kiruna has also become a customer. Other new customers within the energy sector include Borås Energi and Växjö Energi. The primary use case is technical support directly to the end customer where a remote guidance call can replace a physical visit or make sure that a

OmniCar Holding AB: Omnicar Holding Q1 2022 report

Dear shareholders I am pleased to present to you our Q1 report and to emphasise once again that we are adhering to our ambitious growth plan of making life easier for car owners throughout Denmark day by day - attached our Q1 2022 report and below som of our achieved milesstones Significant milestones achieved during Q1 2022:· 80% total revenue growth from Q1 2021 to Q2 2022 · 170% revenue growth on service business from Q1 2021 to Q1 2022 · Still rated Denmark’s best workshop (based on more than 1,600 ratings) · More than 6,500 vehicles serviced · Nationwide coverage ·

The best Queen Elizabeth II magazine covers of all time

The Queen and her Corgi dog featured on the front of The Lady magazine ‘The Life and Times of the Royal Corgis’ has been voted the favourite Queen Elizabeth cover according to a poll by digital magazine and newspaper app, Readly.  The subscription service reveals the top Queen Elizabeth covers as it launches the Queen’s Jubilee digital magazine collection. From her relationship with her family and much loved corgi’s, to historical moments on the throne and modern iconic photography, the top three Queen Elizabeth covers as voted by Readly subscribers are The Lady (November 2018)

Saab Receives Orders for Carl-Gustaf Components

Saab has received orders for components for the Carl-Gustaf® recoilless rifle. The total order value is SEK 643 million and deliveries will take place during 2022 and 2023.The industry’s nature is such that, depending on circumstances concerning the product and customer, further information regarding the customer will not be announced. “We continue to support and strengthen our customers’ defence capabilities with our world-leading ground combat solutions. This order is further proof that our solutions meet our customers’ requirements,” says Görgen Johansson, head of Saab’s business area

Norse Atlantic Airways launches ticket sales between London Gatwick and New York JFK with return fares starting from £255

Today, Norse Atlantic Airways has opened ticket sales for flights between London Gatwick and New York JFK on www.flynorse.com. UK customers will be able to take advantage of affordable fares and enjoy a quality service on board modern Boeing 787 Dreamliner aircraft. The daily direct service will commence on 12th August 2022.Fares will start from as low as £255 return, including all applicable taxes. The first flight departing London Gatwick to New York (JFK) will take place on 12th August 2022. Norse Atlantic will offer a daily service between the UK and the US. Other US destinations will

UPM Raflatac accelerates its growth in label materials and enters new product segments by acquiring AMC AG

(UPM Raflatac, Helsinki, 27 May 2022 at 10.00 EEST) – UPM Raflatac has signed an agreement to acquire AMC AG (Advanced Methods of Coating), a Germany-based company. This acquisition accelerates growth and expands the product offering of UPM Raflatac. Both parties have agreed not to disclose the purchase price or other transaction details. The transaction is expected to be closed latest in Q3, 2022. The closing of the acquisition is subject to regulatory approvals. AMC Hagenow With this acquisition, UPM continues in its strategic path, adding to the organic growth in the

Veidekke: Mandatory notification of trade – Exercise of employee share options in Veidekke ASA

With reference to the stock exchange announcement dated May 23, 2022, primary insider notifications pursuant to the market abuse regulation article 19 are attached. For further information, please contact: Jørgen Wiese Porsmyr, CFO, +47 907 59 058, jorgen-wiese.porsmyr@veidekke.no This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

TOMRA: Ex share split today

Reference is made to the key information published by TOMRA Systems ASA on February 25 and March 8, 2022. The shares in TOMRA Systems ASA will be traded ex split, new ISIN and new face value as from today 27 May 2022. Issuer name: TOMRA Systems ASA Type of corporate action: share split Split ratio: one (1) old share will give two (2) new shares Ex-date: 27 May 2022 New ISIN after split: NO0012470089 Following completion of the share split, the new number of issued underlying shares of TOMRA Systems ASA will be 296,040,156, each with a par value of NOK 0.50 per share.

Aiforia releases another CE-IVD marked clinical AI Model — expanding its diagnostic pathology offering to prostate cancer

Aiforia Technologies Plc, Press Release, 27 May, 2022 at 09.30 a.m. EEST. Aiforia Technologies Plc announces the CE-IVD marking of the Aiforia® Clinical AI Model for Prostate Cancer; Gleason Grade Groups. This latest regulatory certification brings Aiforia’s portfolio of AI-powered diagnostic tools to a total of 5 CE-IVD marked clinical AI models for breast, lung, and now prostate cancer — the most commonly occurring cancer in men.According to the World Cancer Research Fund, more than 1.4 million new cases of prostate cancer were diagnosed in 2020. Both pathologists and patients deserve

Musti Group plc – Managers' transactions – Rannikko

Musti Group plc – Managers' transactions – Rannikko Musti Group plc            Managers’ transactions                  27 May 2022, at 9.30am Musti Group Oyj - Managers’ transactions                  ____________________________________________ Person subject to the notification requirement Name: Toni Rannikko Position: Chief Financial Officer Issuer: Musti Group Oyj LEI: 743700IE9NQGF9YZAI97 Notification type: INITIAL NOTIFICATION Reference number: 15556/5/4 ____________________________________________ Transaction date: 2022-05-25 Venue: NASDAQ

Handelsbanken Fonder changes auditor

Today's Annual General Meeting in Handelsbanken Fonder AB appointed PricewaterhouseCoopers (PwC) as auditor for the Management Company, with the authorized public accountant Helena Kaiser de Carolis as auditor in charge. PwC will also be the auditor for the mutual funds managed by the Management Company, including its exchange-traded funds and Helena Kaiser de Carolis will also serve as the auditor in charge for the Management Company’s mutual funds. PwC will replace Ernst & Young (auditor in charge, Jesper Nilsson) as the auditing firm.  For further information, please contact:

Esmaeilzadeh Holding AB publishes report for the first quarter 2022

“During the first quarter, EHAB strengthened its cash position with a bond loan of SEK 1.2 billion and is therefore in a very good position to finance the high level of activity in our portfolio. At the same time, EHAB continues to pursue its strategic and long-term initiatives to achieve economies of scale and to streamline and consolidate the portfolio, which we believe will benefit both investors and our portfolio companies.” - Saeid Esmaeilzadeh, CEO Financial overview · Total net asset value was SEK 4,374 million (SEK 277 million), equivalent to SEK 5,770 per share (SEK 1,107)

Lytix Biopharma AS announces that an abstract on LTX-315 in combination with Adoptive Cell Therapy is selected for a poster presentation at ASCO 2022

Oslo, Norway, May 27, 2022 – Lytix Biopharma AS (“Lytix” or the “Company”), a clinical-stage company with an in situ vaccination technology platform, announces that an abstract relating to LTX-315 in combination with Adoptive Cell Therapy (ACT) has been selected for presentation at a Poster Session during American Society of Clinical Oncology (ASCO) 2022. LTX-315 is a first-in-class oncolytic molecule, representing a new and superior in situ therapeutic vaccination principle to boost the clonal expansion of T cells and subsequent anti-cancer immunity.Immune- and clinical response data from

There are no items matching the current filter
There are no more items matching the current filter
Back to top